查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1993148

人工骨市场：按材料、分销管道、应用和最终用户划分－2026-2032年全球市场预测

Artificial Bone Market by Material, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年人造骨市场价值18亿美元，预计2026年将成长至19.1亿美元，复合年增长率为5.77%，到2032年将达到26.7亿美元。

主要市场统计数据
基准年 2025 18亿美元
预计年份：2026年 19.1亿美元
预测年份 2032 26.7亿美元
复合年增长率 (%) 5.77%

本文简要概述了不断发展的人工骨领域，其中生物材料的进步与外科手术、监管和供应链的现实情况相互交织。

人工骨领域正处于生物材料创新、外科技术进步和不断发展的医疗服务模式的交汇点。合成支架的进步、整合策略的改进以及更精准的手术器械的出现，重新定义了骨修復和重组的临床预期。这些技术进步与微创手术需求的成长、门诊服务的扩展以及对成本效益和患者长期疗效日益重视的趋势相辅相成。

生物材料、製造、临床证据产生和供应链整合的创新融合如何重新定义人工骨解决方案。

该产业正在发生多项变革性变化，重塑产品设计、临床应用和竞争格局。首先，材料科学的创新正从传统的异体移植扩展到高性能合成解决方案，这些解决方案具有可调控的生物降解性、增强的骨诱导性和客製化的机械性能。生物活性玻璃、羟基磷灰石复合材料、聚合物共混物和磷酸三钙配方的进步，使开发人员能够设计出更真实地模拟活体骨骼微环境的支架。

评估关税措施对人造骨生态系统在供应链、采购经济性和筹资策略。

2025年推出的政策变化和关税措施带来了新的变数，企业和医疗系统必须在产业计画中加以考虑。如果原料、成品植入或专用设备来自海外，那么对某些医疗进口产品提高关税将立即影响成本结构。高度依赖受影响贸易路线的机构正面临采购复杂性增加和价格压力增加的局面。

识别材料、临床应用、终端用户采纳和分销方式方面的差异化管道，以提高产品市场适用性。

市场细分揭示了每种材料、临床应用、终端用户和分销管道中存在的微妙机会和风险区域。从材料角度来看，市场由生物衍生材料和合成材料所构成，同种异体移植和异质骨移植产品正与越来越多的合成替代品竞争。合成材料本身种类繁多，包括生物活性玻璃、羟基磷灰石、金属替代品、聚合物复合复合材料和磷酸三钙基配方，每种材料都有其独特的操作特性、降解特性和成本影响。这些材料差异会影响外科医生的选择、监管核准流程和生产要求。

为了引导策略性市场进入，我们绘製了美洲、欧洲、中东和非洲以及亚太地区的创新、监管多样性和采用趋势图。

区域趋势揭示了独特的创新中心、法规环境和商业性压力如何影响策略。在美洲，完善的医疗保健网络、强大的临床研究能力和成熟的报销体系为新材料和医疗设备的快速临床检验和应用提供了支援。该地区先进的医院和门诊基础设施催生了对能够切实改善患者疗效和提升营运效率的解决方案的需求。

市场领导和创新专家如何将临床证据、垂直整合和数位服务结合，以建立强大的竞争优势。

如今，竞争格局正日益受到超越基本产品特性的能力所限制。主要企业和专业创新者正加大对更全面的临床证据包的投资，构建结合支架材料和生物佐剂的多功能平台，并与临床中心建立战略合作伙伴关係，以加速真实世界检验。一些企业优先考虑垂直整合，以管理关键投入并降低供应中断的风险，而其他企业则专注于敏捷的製造地和快速的产品线改进。

针对製造商和供应商的具体策略措施，以扩大招募规模、加强供应链并加速临床和商业性检验。

产业领导企业可以采取一系列切实可行的措施来降低风险，同时利用发展动能。优先投资于兼顾生物性能和生产规模化的合成材料平台至关重要，重点关注易于操作且降解特性符合临床需求的配方，例如生物活性玻璃、羟基磷灰石混合物、聚合物复合材料和磷酸三钙。同时，他们还应透过有针对性的註册研究、研究者主导的临床研究以及与大型手术中心的合作，扩大临床证据的积累，从而加速关键意见领袖（KOL）对这些技术的认可。

为了确保获得可操作的见解，我们采用了多层次和检验的研究设计，结合了第二手资料的整合、对临床医生和采购负责人的直接访谈、供应链映射和情境分析。

本研究途径整合了来自不同资讯来源的见解，并结合了多层次的调查方法，旨在检验商业性和临床主题。二手研究整合了同行评审文献、监管文件、临床指南和公共采购公告，以建立技术和政策基准背景。一手研究包括对骨科医生、牙医、医院采购负责人、门诊手术中心管理人员和研究机构的研究人员进行结构化访谈和定性讨论，以捕捉细微的临床偏好和采购行为。

将材料创新、临床检验和营运韧性整合到一个系统中，以确定哪种人工骨解决方案将成为治疗标准。

人工骨领域正从关注基础植入材料转向以工程解决方案、数据驱动的证据包和稳健的商业模式为主导的格局。材料创新拓展了治疗选择，而生产和分销方式的变革则实现了更个人化、特异性患者的照护。政策和价格的变化凸显了供应链灵活性和在地化生产策略的重要性，而临床医生则要求提供严谨的真实世界证据来支持其应用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 人工骨市场：依材料划分

  • 同种异体移植
  • 合成
    • 生物活性玻璃
    • 羟磷石灰
    • 金属替代材料
    • 聚合物复合材料
    • 磷酸三钙
  • 异质骨移植

第九章：人造骨市场：依通路划分

  • 直销
  • 销售代理
    • 电子商务合作伙伴
    • 医疗设备销售代理
  • 线上管道
    • 製造商网站
    • 第三方平台

第十章 人工骨市场：依应用领域划分

  • 牙科
    • 植入
    • 牙周
  • 神经病学
  • 整形外科
    • 关节重组
    • 脊椎融合手术
    • 创伤修復

第十一章：人工骨市场：依最终用户划分

  • 门诊手术中心
  • 牙医诊所
  • 医院
  • 研究机构
    • 临床研究
    • 临床前研究

第十二章 人工骨市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：人工骨市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：人造骨市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国人工骨市场

第十六章 中国人工骨市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advanced Medical Solutions Group plc
  • Aesculap, Inc.
  • Allosource
  • B. Braun Melsungen AG by Octane Medical Group
  • Bando Chemical Industries Ltd.
  • Baxter International, Inc.
  • Bioventus LLC
  • Bone Biologics Corp
  • ConforMIS, Inc. by restor3d
  • curasan AG
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Graftys SA
  • Integra LifeSciences Holdings Corporation
  • Johnson &Johnson
  • Medtronic plc
  • NovaBone by Halma PLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • OssDsign AB
  • Ossur hf.
  • RTI Surgical Holdings, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-1A1A064C02DD

The Artificial Bone Market was valued at USD 1.80 billion in 2025 and is projected to grow to USD 1.91 billion in 2026, with a CAGR of 5.77%, reaching USD 2.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.80 billion
Estimated Year [2026] USD 1.91 billion
Forecast Year [2032] USD 2.67 billion
CAGR (%) 5.77%

A concise orientation to the evolving artificial bone field where biomaterial advances intersect with surgical, regulatory, and supply chain realities

The artificial bone landscape sits at the confluence of biomaterials innovation, surgical technique evolution, and shifting healthcare delivery models. Advances in synthetic scaffolds, improved biological integration strategies, and more precise surgical tools have recalibrated clinical expectations for bone repair and reconstruction. These technological developments coincide with rising demand for minimally invasive procedures, outpatient care expansion, and an increased emphasis on cost-effectiveness and long-term patient outcomes.

Clinical leaders and procurement teams now evaluate products not only for initial handling and osteoconductivity, but for demonstrated healing trajectories, infection resistance, and compatibility with adjunctive therapies such as growth factors or cell-based approaches. Regulatory scrutiny has tightened in many jurisdictions, raising the bar for robust clinical evidence and post-market surveillance. Meanwhile, supply chain resilience and manufacturing scalability have become board-level concerns as providers seek reliable partners capable of consistent quality and responsive logistics.

Against this backdrop, stakeholders must balance innovation with reproducibility. Emerging materials and digital manufacturing techniques offer promise, yet adoption hinges on clear, reproducible clinical benefits, streamlined reimbursement pathways, and practical considerations for hospitals, clinics, and ambulatory surgical centers. The following analysis synthesizes these dynamics to orient strategy across product development, market entry, and commercial execution.

How converging innovations in biomaterials, manufacturing, clinical evidence generation, and supply integration are redefining artificial bone solutions

The industry is experiencing several transformative shifts that are reshaping product design, clinical adoption, and competitive positioning. First, materials science innovations have expanded beyond traditional allografts to high-performance synthetic solutions that offer tunable biodegradation, enhanced osteoinduction, and tailored mechanical properties. Progress in bioactive glass, hydroxyapatite composites, polymer blends, and tricalcium phosphate formulations has allowed developers to engineer scaffolds that more closely mimic native bone microenvironments.

Second, manufacturing approaches such as additive manufacturing and precision machining are enabling patient-specific implants and porous architectures that optimize vascularization and load transfer. These capabilities are altering surgeon preferences by improving intraoperative fit and reducing the need for secondary procedures. Concurrently, improvements in sterilization, packaging, and cold-chain logistics have lowered infection risks and expanded the practical use of biologic-derived materials.

Third, the competitive landscape is shifting as companies prioritize vertical integration, strategic partnerships with clinical centers, and the development of consolidated data packages that include clinical outcomes, cost-effectiveness analyses, and real-world evidence. Health systems are increasingly demanding demonstrable value, creating incentives for suppliers to align product profiles with reimbursement criteria and bundled care pathways. Together, these shifts are accelerating a market evolution from commodity grafting materials to sophisticated, clinically validated therapeutic platforms.

Assessing the strategic consequences of tariff measures on supply chains, procurement economics, and sourcing strategies in the artificial bone ecosystem

Policy changes and tariff measures introduced in 2025 have introduced new variables that companies and health systems must account for in operational planning. Increased duties on certain medical imports have immediate implications for cost structures where raw materials, finished implants, or specialized instrumentation are sourced internationally. Organizations with a concentrated exposure to affected trade lanes have faced enhanced procurement complexity and pricing pressure.

In response, manufacturers and distributors are adapting by reshaping supply chains to mitigate tariff-related risk. Some entities have accelerated nearshoring of component supply, established contingency stocking strategies, or diversified supplier portfolios to reduce dependence on tariff-impacted regions. Others have reassessed their product portfolios to prioritize locally manufactured lines or to reformulate products to leverage materials with lower import sensitivity.

Clinicians and purchasing leaders are adjusting tender specifications and total-cost-of-ownership evaluations to capture the downstream effects of tariffs on inventory turnover, device availability, and contractual pricing. At the same time, tariff-driven cost inflation is driving greater emphasis on clinical differentiation and demonstrable outcome improvements to justify price adjustments. Taken together, the cumulative impact is a recalibration of commercial models, with a renewed premium on supply chain transparency, supplier flexibility, and localized manufacturing capabilities.

Uncovering differentiated pathways for materials, clinical applications, end-user adoption, and distribution modes to sharpen product and market fit

Segmentation reveals nuanced opportunity pockets and risk zones across material types, clinical applications, end users, and distribution channels. From a materials standpoint, the market is shaped by biological and synthetic options, with allograft and xenograft offerings competing alongside a growing set of synthetic alternatives. Synthetic materials themselves vary widely, including formulations based on bioactive glass, hydroxyapatite, metal substitutes, polymer composites, and tricalcium phosphate, each presenting distinct handling characteristics, degradation profiles, and cost implications. These material distinctions influence surgeon selection, regulatory pathways, and manufacturing requirements.

Application segmentation clarifies clinical demand drivers. Dental applications encompass implantology and periodontal procedures that favor smaller, highly controlled grafts and devices that integrate with dental implant workflows. Neurological uses, particularly cranioplasty, require materials optimized for contouring, infection resistance, and long-term structural support. Orthopedic applications span joint reconstruction, spinal fusion, and trauma repair, where load-bearing capacity, osteointegration speed, and compatibility with fixation hardware are paramount. Each application imposes different evidence requirements and procurement behaviors.

End-user segmentation highlights divergent purchasing dynamics and clinical priorities. Ambulatory surgical centers prioritize products that enable rapid turnover and predictable handling, while dental clinics focus on aesthetic outcomes and integration with restorative workflows. Hospitals evaluate devices across broader clinical pathways and cost frameworks, and research institutes-both clinical and preclinical-drive innovation and early-stage validation, influencing later adoption. Distribution channel segmentation reflects multiple go-to-market approaches, from direct sales relationships to distributor networks and online channels. Distributors include e-commerce partners and specialized medical device distributors, while online channels consist of manufacturer websites and third-party platforms, creating layered opportunities for outreach, service, and logistics optimization.

Mapping regional innovation, regulatory diversity, and adoption dynamics across the Americas, Europe Middle East Africa, and Asia-Pacific to guide strategic entry

Regional dynamics reveal distinct innovation centers, regulatory environments, and commercial pressures that shape strategy. In the Americas, established healthcare networks, substantial clinical research capacity, and mature reimbursement systems support rapid clinical validation and adoption of novel materials and devices. The region's sophisticated hospital and outpatient infrastructure creates demand for solutions that deliver demonstrable improvements in patient outcomes and operational efficiency.

Europe, the Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with country-specific reimbursement and procurement practices. Manufacturers must navigate varied approval timelines and evidence expectations, while competitive tendering and cost containment policies can influence pricing strategies. Adoption in certain markets is accelerated by strong public health programs and concentrated research centers that serve as early adopters.

Asia-Pacific is characterized by rapid capacity building, both in manufacturing and clinical adoption, with several economies investing heavily in localized production and regenerative medicine research. Market trajectories in this region are driven by demographic shifts, growing private care segments, and expanding access to elective orthopedic and dental procedures. Across regions, differences in surgeon training, payer models, and supply chain infrastructure necessitate tailored commercial and regulatory strategies rather than one-size-fits-all approaches.

How market leaders and specialized innovators are combining clinical evidence, vertical integration, and digital services to create defensible positions

Competitive dynamics are increasingly defined by capabilities beyond basic product attributes. Leading firms and specialist innovators are investing in deeper clinical evidence packages, creating multifunctional platforms that combine scaffolding with biological adjuncts, and pursuing strategic partnerships with clinical centers to accelerate real-world validation. Some organizations are prioritizing vertical integration to control critical inputs and to reduce exposure to supply disruptions, while others focus on nimble manufacturing footprints and rapid iteration of product families.

Mergers and acquisitions remain an important route for accessing complementary technologies, regulatory pathways, and established distribution networks. At the same time, open innovation models and collaborative research agreements with academic centers and contract manufacturers are enabling faster translation of laboratory advances into viable commercial products. Companies that excel are those that align R&D roadmaps with clear reimbursement pathways and that build commercial teams capable of articulating value in clinical and economic terms.

Moreover, a growing number of players are investing in digital services-such as clinician training platforms, procedural planning tools, and post-market surveillance dashboards-to differentiate offerings and deepen customer relationships. Success increasingly depends on an integrated approach that combines material science, clinical evidence, supply chain reliability, and compelling commercial support.

Concrete strategic moves for manufacturers and suppliers to expand adoption, fortify supply chains, and accelerate clinical and commercial validation

Industry leaders can pursue a set of pragmatic actions to capitalize on momentum while mitigating risk. Prioritize investment in synthetic material platforms that balance biological performance with manufacturing scalability, focusing on formulations such as bioactive glass, hydroxyapatite blends, polymer composites, and tricalcium phosphate where handling and degradation profiles meet clinical needs. Concurrently, expand clinical evidence generation through targeted registries, investigator-initiated studies, and partnerships with high-volume surgical centers to accelerate acceptance among key opinion leaders.

Strengthen supply chain resilience by diversifying suppliers, exploring nearshoring options, and implementing dual-sourcing for critical inputs. Align commercial strategies with channel realities: optimize direct sales where clinical support and training drive adoption, leverage distributor networks for broader geographic reach, and develop compelling digital storefronts for repeatable, lower-complexity products. Coordinate these efforts with reimbursement-oriented health economic data to facilitate inclusion in bundled care pathways and hospital formularies.

Finally, invest in post-market surveillance and digital value-added services to capture outcomes data that support iterative product improvement and payer negotiations. In parallel, maintain flexibility in pricing and contracting to respond to tariff impacts and local procurement dynamics. These actions together create a resilient, evidence-driven commercial model capable of sustaining growth across variable regional and regulatory environments.

A layered and validated research design combining secondary synthesis, primary clinician and procurement interviews, supply chain mapping, and scenario analysis to ensure actionable insights

The research approach combined a layered methodology designed to triangulate insights from diverse sources and to validate commercial and clinical themes. Secondary research synthesized peer-reviewed literature, regulatory filings, clinical guidelines, and public procurement notices to establish baseline technical and policy contexts. Primary research included structured interviews and qualitative discussions with orthopedic and dental surgeons, hospital procurement officers, ambulatory surgical center managers, and research institute investigators to capture nuanced clinical preferences and purchasing behaviors.

Supply chain assessments mapped supplier concentrations, manufacturing footprints, and logistical constraints, while product-level analyses examined material compositions, sterilization methods, handling profiles, and documented clinical outcomes. Case studies of representative product launches and procurement decisions illuminated real-world adoption patterns and contracting dynamics. Data quality was assured through cross-validation across sources, reconciliation of conflicting inputs, and iterative stakeholder feedback.

Where appropriate, scenario analysis was used to test the sensitivity of strategic options to regulatory shifts, tariff regimes, and adoption curves. The methodology prioritized transparency in assumptions and traceability of sources to support client-specific inquiries and to facilitate reproducibility of key analytical findings.

Synthesis of how material innovation, clinical validation, and operational resilience will determine which artificial bone solutions become standard of care

The artificial bone sector is transitioning from a focus on basic graft materials to a landscape defined by engineered solutions, data-driven evidence packages, and resilient commercial models. Material innovations are expanding therapeutic options while manufacturing and distribution shifts are enabling more tailored and patient-specific care. Policy and tariff changes underscore the importance of supply chain agility and local manufacturing strategies, even as clinicians demand rigorous, real-world evidence to support adoption.

Companies that combine rigorous clinical validation with flexible manufacturing, strategic channel alignment, and strong post-market data capabilities will be best positioned to capture opportunity. Health systems and providers will favor partners who deliver consistent quality, clear value propositions, and support for operational workflows. Looking ahead, alignment between product design, regulatory strategy, and payer engagement will determine which innovations move from promising research to routine clinical practice.

The findings point toward a future in which integrated solutions-materials plus clinical services and digital tools-reshape how bone repair therapies are evaluated, procured, and delivered, creating durable commercial advantages for organizations that act decisively.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Bone Market, by Material

  • 8.1. Allograft
  • 8.2. Synthetic
    • 8.2.1. Bioactive Glass
    • 8.2.2. Hydroxyapatite
    • 8.2.3. Metal Substitute
    • 8.2.4. Polymer Composite
    • 8.2.5. Tricalcium Phosphate
  • 8.3. Xenograft

9. Artificial Bone Market, by Distribution Channel

  • 9.1. Direct Sales
  • 9.2. Distributors
    • 9.2.1. E-commerce Partners
    • 9.2.2. Medical Device Distributors
  • 9.3. Online Channels
    • 9.3.1. Manufacturer Websites
    • 9.3.2. Third Party Platforms

10. Artificial Bone Market, by Application

  • 10.1. Dental
    • 10.1.1. Implantology
    • 10.1.2. Periodontal
  • 10.2. Neurological
  • 10.3. Orthopedic
    • 10.3.1. Joint Reconstruction
    • 10.3.2. Spinal Fusion
    • 10.3.3. Trauma Repair

11. Artificial Bone Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Dental Clinics
  • 11.3. Hospitals
  • 11.4. Research Institutes
    • 11.4.1. Clinical Research
    • 11.4.2. Preclinical Research

12. Artificial Bone Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Artificial Bone Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Bone Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Artificial Bone Market

16. China Artificial Bone Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced Medical Solutions Group plc
  • 17.6. Aesculap, Inc.
  • 17.7. Allosource
  • 17.8. B. Braun Melsungen AG by Octane Medical Group
  • 17.9. Bando Chemical Industries Ltd.
  • 17.10. Baxter International, Inc.
  • 17.11. Bioventus LLC
  • 17.12. Bone Biologics Corp
  • 17.13. ConforMIS, Inc. by restor3d
  • 17.14. curasan AG
  • 17.15. Exactech, Inc.
  • 17.16. Globus Medical, Inc.
  • 17.17. Graftys SA
  • 17.18. Integra LifeSciences Holdings Corporation
  • 17.19. Johnson &Johnson
  • 17.20. Medtronic plc
  • 17.21. NovaBone by Halma PLC
  • 17.22. NuVasive, Inc.
  • 17.23. Orthofix Medical Inc.
  • 17.24. OssDsign AB
  • 17.25. Ossur hf.
  • 17.26. RTI Surgical Holdings, Inc.
  • 17.27. Smith & Nephew plc
  • 17.28. Stryker Corporation
  • 17.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL BONE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL BONE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ALLOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ALLOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY BIOACTIVE GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY BIOACTIVE GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY BIOACTIVE GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY METAL SUBSTITUTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY METAL SUBSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY METAL SUBSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY POLYMER COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY POLYMER COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY POLYMER COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY E-COMMERCE PARTNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY E-COMMERCE PARTNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY E-COMMERCE PARTNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PERIODONTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PERIODONTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PERIODONTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SPINAL FUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SPINAL FUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 200. GCC ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. GCC ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 203. GCC ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. GCC ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 206. GCC ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. GCC ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 208. GCC ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 209. GCC ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. GCC ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 233. G7 ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. G7 ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 236. G7 ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. G7 ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 239. G7 ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 241. G7 ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 242. G7 ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 244. NATO ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 246. NATO ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 247. NATO ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. NATO ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. NATO ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 252. NATO ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 253. NATO ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. NATO ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)